Gastrointestinal Cancer
News
Ramucirumab may expand treatment options for metastatic colorectal cancer
Key clinical point: Adding ramucirumab to second-line chemotherapy delayed progression and prolonged survival, with manageable toxicity. Major...
Conference Coverage
Skipping surgery is an option for some patients with rectal cancer
Key clinical point: Patients with rectal cancer who have a clinical complete response to neoadjuvant therapy can safely skip surgery. Major...
News
Outcomes of stage III colon cancer appear better for aspirin, COX-2 inhibitor users
Key clinical point: Among patients with stage III colon cancer, users of aspirin or COX-2 inhibitors appear less likely to have a recurrence and...
News
TRIBE update: FOLFOXIRI-bevacizumab boosts survival in metastatic CRC
Key clinical point: Long-term survival was better with FOLFOXIRI-bevacizumab than with FOLFIRI-bevacizumab. Major finding: Median overall survival...
News
Microbiota organization influences colorectal cancers
Key clinical point: The organization of the mucosa-associated microbial community is an important factor in CRC pathogenesis, particularly in the...
News
Stage, lymph node status should drive gastric cancer treatment decisions
Key clinical point: Lymph node status and the Laurén classification should be taken into account in the management of patients with gastric cancer...